Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB

As the trading week approaches, now is an opportune moment for investors to delve deeper into companies garnering recent attention. This feature will offer insights into five such stocks. 

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) has shown robust performance recently, accompanied by a significant increase in trading volume. Since March 20, the stock has surged by 121% and closed at $2.95 per share on April 11, driven by a prolonged short squeeze. On March 27, the company released its financial results for the fiscal year ending January 31, 2024. Quarterly revenues rose to $3.2 million from $2.5 million in the corresponding period last year, mainly due to reduced credits issued to customers. The net loss for the quarter was $2.2 million, marking a decrease from the previous year’s net loss of $3 million. 

Intelligent Bio Solutions Inc. (NASDAQ: INBS), a key player in the medical technology sector, specializes in providing fast, non-invasive, and intelligent testing solutions. Ladenburg Thalmann, a well-known Wall Street institution established in 1876, issued a buy recommendation for Intelligent Bio Solutions Inc. stock, setting a target price of $12 per share. Furthermore, on March 11, the company announced raising $10.1 million through a private placement involving accredited investors in the healthcare sector and institutional investors. On April 11, the company expanded the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, by securing a new European patent with unitary effect for its innovative DSR-Plus Cartridge Reader. 

General Enterprise Ventures Inc. (OTC: GEVI) gained recognition primarily for the advancements made by its subsidiary, Mighty Fire Breaker LLC (MFB), in the field of fire-retardant solutions. In April, it was revealed that Joshua Robinson, the Chief Executive Officer of General Enterprise Ventures Inc., had returned 60% of the company’s outstanding common stock shares to the Treasury, a move expected to significantly enhance shareholder value. On April 2, news surfaced about a collaboration between SkyScout Ai Innovations and MFB’s Value-Add Wildfire Reduction Team, signaling MFB’s entry into the Canadian market with its fire-retardant product CitroTech. 

Catheter Precision Inc. (NYSE American: VTAK) was highlighted in a Ladenburg Thalmann research report on April 5, 2023, with a buy recommendation and a $4 target price for the next year. On April 1, the company reported its Q4 and full fiscal year results for 2023, showing total assets of $30.7 million, a cash balance of $3.6 million, and notable revenue growth compared to the previous year. The company also reduced its net loss in the fourth quarter to $0.7 million from $8.2 million. Additionally, on April 4, Catheter Precision expanded its business development team with industry professionals to drive sales growth and market expansion. 

Rallybio Corporation (NASDAQ: RLYB) gained attention on April 10 following its announcement of a collaboration with Johnson & Johnson (NYSE: JNJ). Under the agreement, Rallybio Corporation will assist in developing complementary therapeutic methods to reduce the risk of FNAIT (fetal and neonatal alloimmune thrombocytopenia). Additionally, Johnson & Johnson Innovations invested $6.6 million in Rallybio Corporation as part of the collaboration.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB

Ituran Increases Dividend To 6% After Posting Record-Setting 2023 Operational Performance ($ITRN)

Ituran Location and Control (NASDAQ: ITRN) presents a compelling investment proposition. In fact, with a forward-looking dividend yield of 6%, this innovative technology company, which averages roughly 57,000 shares traded daily, may present a value disconnect too wide to ignore. That’s not an overly aggressive assessment, either. Considering this company posted record across-the-board financial metrics, including a 9% revenue increase in year-over-year to $320 million, net income of $48 million, an increase of 30% year-over-year, and a 10% increase in EBITDA to $87 million, ITRN’s market cap of $530 million, while impressive by most listing standards, may actually fall short of an appropriate fair value.

An analyst at Barclay’s covering ITRN stock makes that case, modeling a 12-month price target for ITRN shares to reach $35, over 30% higher than its current price. That expectation is bullish but not overly so. In addition to its record revenues, the company also generated $77 million in FY2023 operating cash flow as it continues to earn deals from global companies interested in its revolutionary telematics and connected car ecosystem. The interest is warranted. While some of ITRN’s competitors do one of two things well, Ituran does many by leveraging strength from a full spectrum of innovative software solutions, in-vehicle sensors, and unique services and system functionality that do more than address challenges; they overcome them.

That distinction can do more than drive revenues higher from already record levels; it also supports the evidence-based case that the path of least resistance for ITRN shares is currently paved higher.

Ituran is Ushering in the Shift in Mobility Technology 

The bullish expectation is justified, especially as Ituran continues strengthening its leadership position in the emerging mobility technology field by providing value-added location-based services, particularly its full suite of services for the modern connected car. While under the radar of investors, that’s not the case from a client-and-use perspective.

Served by its 2,800 employees from offices worldwide, Ituran is the largest OEM telematics provider in Latin America, with its products and applications used by customers in over 20 countries. And a lot of them. By the end of 2023, subscribers wanting Ituran products and services reached almost 2.3 million subscribers increasing by 186,000 during the year and meeting growth guidance despite the challenging economic and geopolitical market landscapes.

In addition to scoring record operating performances, Ituran ended the year financially solid, with year-end net cash and marketable securities of $53 million. Here’s the better news from those investors liking to get “paid to wait” for growth. In Q4, Ituran added to its dividend distribution accounts and bought back over $6.6 million in shares, representing a 6% passive income yield and a value driver from a forward-looking valuation perspective, respectively. The latter is significant, considering that the company only has about 20 million shares outstanding on a fully diluted basis.

Operating Momentum After an Impressive Q4/2023

Attracting investors and supporting the bullish analyst model is that year-end results were strengthened by an impressive Q4. For the period, net subscriber growth, meaning recurring revenue stream providers, increased by 42,000 when combining the new aftermarket subscribers of 38,000 with the net increase in OEM subscribers of 4,000. Revenues increased by 4% to $78 million, leading to net income of $12 million, 26% higher than a year ago. The performance prompted the Board to increase the dividend policy by 60% to $8 million for the quarter, a run rate of $32 million per year, based on the growing profitability and strong operating cash flow.

It also led to optimistic guidance about expectations in 2024. Management said it expects to add approximately 35,000 to 40,000 net new subscribers each quarter during 2024, contributing to EBITDA projections between $90-95 million. In 2025, EBITDA is targeted to surpass $100 million. Management did note that these targets are based on current exchange rates and assume that Israel’s current global macroeconomic situation and political situation do not significantly change. Still, if Mid-East tensions ease, the potential to beat is undoubtedly in play, noting the company’s business resilience during challenging times.

Keep in mind that hardware installations and, therefore, product revenues were paused for at least several weeks following the outbreak of war in Israel on October 7. That caused some declines in a quarterly comparison. However, year-over-year, Ituran accomplished what it and investors want and appreciate- growth. Better still, despite supply-chain issues, gross margins stayed impressive, with subscription revenues at around 58%, and the gross margin on products at 22%. That facilitated Q4 operating income to increase by 8% to $16.5 million compared to $15.3 million in the fourth quarter of last year.

Value Drivers are Active in 2024

From an investor perspective, financial results, interim project updates, and 2024 guidance have guided expectations for the Ituran growth spurt to continue. And the best news from that same standpoint is that the company shares the wealth earned. In addition to the increased dividend, the company will continue its previously announced $25 million share buy-back program, which increased to $35 million, last February. With roughly $6.7 million remaining under that authorization, it’s more than support at the bid; it’s a value driver that can steepen the growth curve trajectory when new milestones are reached.

And there could be many contributing factors. During its recent earnings conference call, ITRN noted that value drivers accrue from different segments, including those created by insurance companies and car owners, especially in Israel, who are looking for effective security systems to protect assets. Because Ituran solutions are considered best-in-class in many respects, it can leverage that distinction and add to already appreciating levels of subscriber growth.

In other countries, Ituran is focused on monetizing market opportunities on the B2B side, working with financial institutions to offer asset protection and security solutions when they provide loans to new car buyers. In Latin America, where there has been an increase in car theft and damage from violence, the company is focused on penetrating those markets more quickly this year to exploit that revenue-generating market opportunity and add traction to its goal of surpassing $100 million in 2025 EBIDTA. That goal is within reach.

Remember, the subscriber base is growing at 9%. And with upsells for its products more the norm than the exception, tracking higher to meet that projection is more than just an ambitious target; it’s in the company’s crosshairs. Coupled with financial efficiencies, a management team committed to ensuring revenues fall faster to its bottom line, and increasing global demand for the kinds of security solutions Ituran provides, this dividend-bearing stock looks very attractive at current levels, even more so with a 6% yield, which could also move higher if guidance is met. In other words, investors could earn while they earn, which may be the ultimate win-win investment proposition.

 

Disclaimers: This content has been created by Hawk Point Media Group, Llc. (HPM) and is responsible for the production and distribution of this content. This presentation should be considered and explicitly regarded as sponsored content. Hawk Point Media Group, LLC. has been compensated twenty-thousand-dollars to create this content as part of a more extensive digital marketing program by an unrelated third party of the company. Accordingly, this content may be used and syndicated beyond the channels used by Hawk Point Media, Llc. This disclaimer and the link to the broader disclosures must be part of all reproductions. That compensation creates a conflict of interest because the content presented may only provide a favorable viewpoint of the company featured. The contributors do NOT buy and sell securities before and after any article, report, or publication. HPM holds ZERO shares and has never owned stock in Ituran Location and Control Ltd. The information in this video, article, and related newsletters is not intended to be, nor does it constitute, investment advice or recommendations. Hawk Point Media Group, Llc. strongly urges you to conduct a complete and independent investigation of the respective companies and consider all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Never take opinions, articles presented, or content provided as the sole reason to invest in any featured company. Investors must always perform their own due diligence before investing in any publicly traded company and understand the risks involved, including losing their entire investment. For the complete disclosure statement, including compensation received, click HERE.

Media Contact
Company Name: Hawk Point Media
Contact Person: Editorial Dept.
Email: info@hawkpointmedia.com
Country: United States
Website: https://ituran.com/ituranglobal/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ituran Increases Dividend To 6% After Posting Record-Setting 2023 Operational Performance ($ITRN)

Exploring Digital Currency Trading Platforms Suitable for Novice Investors in Indonesia

In the current wave of digitalization, interest in digital asset investment is continuously rising. However, for novice investors, understanding the basic principles of digital currencies and their price fluctuations is crucial before entering the field of cryptocurrency trading or capital investment. Moreover, selecting the right digital currency trading platform is a critical first step for novice investors when starting cryptocurrency trading. Choosing a platform that is both stable and secure is essential. In Indonesia, there are many such trading platforms available.

 

Faced with a wide array of digital currency applications on the market, new traders or investors may feel overwhelmed. Choosing a platform that is feature-rich, user-friendly, and provides transaction fee discounts for each trade is particularly important.

Here is a guide from Coinspeaker. The list of digital currency trading platforms in Indonesia includes:

1. PT Aset Digital Berkat (Tokocrypto)

2. PT Aset Kripto Internasional (NVX)

3. PT Bumi Sentosa Cemerlang (Pluang)

4. PT Coinbit Digital Indonesia (Stockbit Crypto)

5. PT Indodax Nasional Indonesia (Indodax)

6. PT Gudang Kripto Indonesia (Gudang Kripto)

7. PT Galad Koin Indonesia (Galad)

8. PT Cipta Koin Digital (Naga)

9. PT CTXG Indonesia Berkarya (Mobee)

10. PT Kagum Teknologi Indonesia (Ajaib Kripto)

11. PT Rekeningku Dotcom Indonesia (REKU)

12. PT Sentra Bitwewe Indonesia (Bitwewe)

13. PT Tumbuh Bersama Nano (Nanovest)

14. PT ZUHYX Exchange Indonesia (ZUHYX)

15. PT Tiga Inti Utama (Triv)

16. PT Luno Indonesia LTD (Luno)

17. PT Upbit Exchange Indonesia (Upbit)

18. PT Pintu Kemana Saja (Pintu)

19. PT Kripto Maksima Koin (KMK)

20. PT Cyrameta Exchange Indonesia (Cyra)

21. PT Zipmex Exchange Indonesia (Zipmex)

22. PT Indonesia Digital Exchange (DEX)

23. PT PT Mitra Kripto Sukses (MKS)

24. PT Utama Aset Digital (Bittime)

25. PT Pedagang Aset Kripto (PAK)

26. PT Ventura Koin Nusantara (Vonix)

27. PT Gerbang Aset Digital (Fasset)

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Coinspeaker
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.coinspeaker.com/

Joseph Samuels of Iset Capital Initiates Prestigious Grant to Elevate Aspiring Musical Theater Artists Nationwide

In a move to cultivate and celebrate emerging talent in the vibrant world of musical theater, Joseph Samuels, esteemed financial strategist and arts advocate, has launched the highly anticipated Joseph Samuels Grant for Musical Theater. This groundbreaking initiative is poised to provide invaluable support and recognition to individuals who harbor a deep passion for musical theater and demonstrate unwavering dedication to artistic excellence.

The Joseph Samuels Grant for Musical Theater, boasting a substantial fund of $1,000, stands as a beacon of hope and opportunity for aspiring artists across the nation. Open to undergraduate students from all corners of the country, this esteemed grant endeavors to propel talented individuals towards realizing their dreams in the competitive landscape of musical theater.

With its diverse array of eligible applicants including playwrights, composers, lyricists, directors, choreographers, performers, and other creative visionaries, the Joseph Samuels Grant for Musical Theater embraces the richness of artistic expression within the realm of musical storytelling. Joseph Samuels, the visionary architect behind this philanthropic endeavor, brings to bear his wealth of experience and expertise as the founder of Islet Capital Management, a leading financial institution renowned for its commitment to innovation and excellence.

A product of Rutgers University–New Brunswick, where he earned a Bachelor of Arts in Economics, Joseph Samuels’ journey from the halls of academia to the pinnacle of the financial world has been marked by a profound appreciation for the arts. His passion for fostering creativity and empowering individuals to pursue their dreams serves as the driving force behind the establishment of this transformative grant.

In envisioning the Joseph Samuels Grant for Musical Theater, Joseph Samuels seeks to bridge the gap between the worlds of finance and the arts, recognizing the symbiotic relationship between financial support and artistic innovation. Through this grant, he endeavors to provide aspiring artists with the resources and encouragement they need to embark on their journey towards artistic fulfillment and professional success.

Applicants for the Joseph Samuels Grant for Musical Theater are invited to submit compelling essays reflecting on their personal journey, their profound passion for musical theater, and their vision for the future. Each applicant is encouraged to articulate how the grant would serve as a catalyst for their artistic growth and development, outlining their aspirations, goals, and the impact they hope to make within the industry.

The application deadline for the Joseph Samuels Grant for Musical Theater is December 15, 2024. Following a rigorous review process, the winner will be announced on January 15, 2025, heralding the dawn of a new chapter in their artistic journey.

For further details and to submit your application, please visit the official website of the Joseph Samuels Grant for Musical Theater: https://josephsamuelsgrant.com/.

About

Joseph Samuels, a visionary leader and philanthropist, is the driving force behind the Joseph Samuels Grant for Musical Theater. With a profound commitment to fostering creativity and nurturing emerging talent, Joseph Samuels seeks to empower aspiring artists to pursue their dreams in the competitive world of musical theater. Through his innovative approach and unwavering dedication, Joseph Samuels aims to bridge the gap between finance and the arts, creating opportunities for artistic expression and cultural enrichment. Join us in celebrating the transformative power of musical theater and the vision of Joseph Samuels.

Media Contact
Company Name: Joseph Samuels Grant
Contact Person: Joseph Samuels
Email: Send Email
City: New York
State: New York
Country: United States
Website: https://josephsamuelsgrant.com

Dr. Paul Carey DDS Scholarship: Fostering Excellence and Compassion in Healthcare

Dr. Paul Carey DDS Scholarship: Fostering Excellence and Compassion in Healthcare

Dr. Paul Carey DDS

Massapequa, NY – The Dr. Paul Carey Scholarship for Medical Students is delighted to announce the commencement of its annual scholarship program, offering a one-time award of $1,000 to support the academic endeavors of promising medical professionals. Established in tribute to Dr. Paul Carey, D.D.S., this esteemed scholarship epitomizes a dedication to academic prowess, patient-centered care, and the advancement of healthcare practices.

The scholarship is open to undergraduate students worldwide who are currently enrolled or have been accepted into accredited medical programs. It is designed to honor individuals who reflect Dr. Carey’s unwavering commitment to academic excellence and compassionate healthcare. Applicants are encouraged to submit a meticulously crafted essay in response to the following prompt: “Reflect on a transformative healthcare experience that has influenced your journey and discuss how it has shaped your aspirations to make a difference in the field.”

Dr. Paul Carey’s illustrious career is marked by a relentless pursuit of knowledge and expertise. A distinguished graduate of Fairfield University and N.Y.U College of Dentistry, Dr. Carey’s journey embodies the epitome of dedication and passion in the field of dentistry. Over the span of 38 years, his contributions as a faculty member at N.Y.U, where he taught Advanced Restorative Techniques, underscore his commitment to academic excellence and mentorship, shaping the future of healthcare professionals.

Applicants for the Dr. Paul Carey Scholarship are expected to demonstrate exceptional academic achievements, a profound commitment to the healthcare sector, and submit an engaging essay that articulates their transformative healthcare experiences. The submission deadline for applications is December 15, 2024, with the scholarship recipient set to be announced on January 15, 2025.

To apply, interested candidates must submit their essay along with their full name, contact information, and proof of enrollment or acceptance to apply@drpaulcareyscholarship.com.

The Dr. Paul Carey Scholarship aspires to empower the next generation of medical leaders by providing financial support and recognition for their outstanding accomplishments. Through this annual essay contest, the scholarship seeks to identify individuals who share Dr. Carey’s vision of excellence and compassion in healthcare, nurturing their potential to make a profound impact in the field.

For comprehensive details regarding the scholarship program, application process, and opportunities for engagement, please visit the official website at https://drpaulcareyscholarship.com/

About Dr. Paul Carey

Dr. Paul Carey, D.D.S., is a distinguished graduate of Fairfield University and N.Y.U College of Dentistry, with over 38 years of dedicated service in dentistry. His specialization in endodontics and proficiency in prosthetic implant technology have garnered him acclaim within the Massapequa community and beyond. The Dr. Paul Carey Scholarship stands as a testament to his enduring legacy, striving to support and inspire the next generation of healthcare professionals in their pursuit of excellence and compassion.

Media Contact
Company Name: Dr. Paul Carey Scholarship
Contact Person: Dr. Paul Carey DDS
Email: Send Email
City: Massapequa
State: New York
Country: United States
Website: https://drpaulcareyscholarship.com

Dr. Tyrone Malloy Scholarship for Medical Students Now Accepting Applications

Dr. Tyrone Malloy Scholarship for Medical Students Now Accepting Applications

Dr. Tyrone Malloy

Decatur, Georgia – Aspiring medical students with a passion for women’s health and a dedication to excellence are invited to apply for the prestigious Dr. Tyrone Malloy Scholarship. Established by Dr. Tyrone Malloy, a distinguished gynecologist, educator, and legal professional, this scholarship aims to support the next generation of medical leaders in advancing healthcare and promoting understanding at the intersection of medicine and law.

Applicants for the Dr. Tyrone Malloy Scholarship will be rigorously evaluated based on academic excellence, a commitment to women’s health, clarity and coherence in writing, research skills, and a strong commitment to excellence in healthcare and education. The scholarship, with a one-time award of $1,000, is open to undergraduate students pursuing a career in medicine.

Dr. Tyrone Malloy, the visionary behind the scholarship, has dedicated his career to the advancement of women’s health and excellence in healthcare and education. His multidisciplinary approach, combining medical expertise with legal acumen, reflects his commitment to ensuring the highest standards of care for patients.

Criteria for Evaluation:

  • Academic Excellence: Demonstrated academic achievement and a strong academic record in medical studies.
  • Passion for Women’s Health: A clear dedication to advancing healthcare in the field of women’s health.
  • Essay Prompt: Applicants must write a 500-word essay on the topic of “The Role of Interdisciplinary Approaches in Advancing Women’s Health,” showcasing their understanding of integrating medical, legal, and social perspectives.
  • Clarity and Coherence: Clear and concise writing style with well-structured arguments and coherent reasoning.
  • Research Skills: Evidence of thorough research on the topic and incorporation of relevant information to support arguments.
  • Commitment to Excellence: Demonstration of a strong commitment to excellence in healthcare, education, and ethical medical practice.

The deadline to apply for the Dr. Tyrone Malloy Scholarship is December 15, 2024. The winner will be announced on January 15, 2025.

About Dr. Tyrone Malloy:

Dr. Tyrone Malloy is a gynecologist, educator, and legal professional dedicated to advancing healthcare, promoting understanding at the intersection of medicine and law, and upholding the highest standards of patient care. He earned his Bachelor’s degree in Biology from New York University and pursued his medical education at Johns Hopkins School of Medicine. Certified by the American Board of OB/GYN, Dr. Malloy’s clinical expertise and commitment to women’s health have earned him respect in the medical community.

For more information about the Dr. Tyrone Malloy Scholarship and how to apply, visit https://drtyronemalloyscholarship.com/dr-tyrone-malloy-scholarship/

Media Contact
Company Name: Dr. Tyrone Malloy Scholarship
Contact Person: Dr. Tyrone Malloy
Email: Send Email
City: Decatur
State: Georgia
Country: United States
Website: https://drtyronemalloyscholarship.com

Dr. Moustafa Moustafa Launches Prestigious Scholarship for Aspiring Doctors

Dr. Moustafa Moustafa Launches Prestigious Scholarship for Aspiring Doctors

Dr. Moustafa Moustafa

Orangeburg, South Carolina – Renowned physician and CEO, Dr. Moustafa Moustafa, proudly introduces the inaugural Dr. Moustafa Moustafa Scholarship for Future Doctors. This esteemed scholarship, valued at $1,000, aims to support the educational pursuits of ambitious undergraduate students across the nation who are dedicated to shaping the future of healthcare.

Dr. Moustafa Moustafa, a distinguished figure in the medical community, spearheads this initiative with the vision of nurturing the next generation of healthcare leaders. With an illustrious background in nephrology and internal medicine, Dr. Moustafa brings a wealth of experience and expertise to this scholarship endeavor.

Students aspiring to pursue a career in medicine are invited to apply for this prestigious scholarship opportunity. Open to those currently enrolled in accredited colleges or universities, the scholarship provides vital financial support to deserving individuals. Applicants are required to submit a compelling essay articulating their motivation for entering the medical profession, along with their envisioned impact on the healthcare field.

Deadline for applications is November 15, 2024, with the winner set to be announced on December 15, 2024.

“It is with great pleasure that I launch the Dr. Moustafa Moustafa  Scholarship for Future Doctors,” states Dr. Moustafa Moustafa. “My aim is to inspire and assist aspiring doctors in their educational journey, empowering them to make significant contributions to the medical community.”

As a testament to his commitment to medical excellence, Dr. Moustafa Moustafa  serves as President of the South Carolina Association of Clinical Research Professionals and is the Founder/President of South Carolina Clinical Research. His dedication to advancing medical knowledge and fostering talent underscores the significance of this scholarship opportunity.

For more information about the Dr. Moustafa Moustafa Scholarship for Future Doctors and to apply, please visit https://drmoustafamoustafascholarship.com/

About

Dr. Moustafa Moustafa, a distinguished physician and CEO of a prominent nephrology practice, is the driving force behind the Dr. Moustafa Moustafa Scholarship for Future Doctors. With a medical degree from the University of Cairo Faculty of Medicine and a specialization in Nephrology and Internal Medicine, Dr. Moustafa brings a wealth of experience and expertise to this scholarship initiative. His commitment to medical excellence is evident through his roles as President of the South Carolina Association of Clinical Research Professionals and Founder/President of South Carolina Clinical Research.

Dr. Moustafa Moustafa’s vision for the scholarship is to nurture the next generation of healthcare professionals by providing financial support and mentorship to aspiring doctors. Through this scholarship, students have the opportunity to not only receive monetary assistance but also benefit from Dr. Moustafa’s guidance and insights gained from years of experience in the medical field. Join us in honoring Dr. Moustafa’s legacy and shaping the future of medicine by applying for this prestigious scholarship today.

Media Contact
Company Name: Dr. Moustafa Moustafa Scholarship
Contact Person: Dr. Moustafa Moustafa
Email: Send Email
City: Orangeburg
State: South Carolina
Country: United States
Website: https://drmoustafamoustafascholarship.com

Truly Clear Launches Revolutionary One-Step Acne Bar for Face and Body

The company’s plant-based, salicylic acid formula offers a quick and effective solution for breakout-prone skin.

APRIL 15, 2024 – Truly Clear, a leading innovator in the skincare industry, has announced the launch of their groundbreaking Truly Clear Acne Bar. This revolutionary product offers a one-step blemish solution for both face and body, combining the power of plant-based ingredients with salicylic acid to cleanse, soothe, and clear breakout-prone skin in under 5 minutes a day.

The non-comedogenic Truly Clear Acne Bar features a refreshing minty aroma and a mess-free application process, eliminating drips or residue on clothing. The bar’s unique formula targets acne, blackheads, and clogged pores with a gentle yet effective approach, providing visible clarifying results in as little as 7 days.

Truly Clear Acne Bar caters to individuals with acne-prone skin seeking a simple and quick solution, as well as those who prefer plant-based skincare products. The versatile acne treatment can be used on various areas, including the face, neck, chest, and back, making it a convenient choice for a wide range of users.

The product’s effectiveness is evident in its impressive customer satisfaction rates, with 97% of customers giving Truly Clear a 4 or 5-star rating. Positive testimonials from users who have experienced improved skin further demonstrate the bar’s efficacy in combating acne and blemishes.

Truly Clear’s success is also reflected in its sales, with over 150,000 units sold, generating $3.5 million in revenue across 6 countries. The company’s commitment to quality is underscored by its adherence to FDA/GMP standards, ensuring a safe and reliable product for its customers.

As the demand for effective, plant-based skincare solutions continues to grow, Truly Clear is well-positioned to meet the needs of consumers seeking a simple and powerful acne treatment for both face and body.

Media Contact
Company Name: Truly Clear
Contact Person: Richard Davidson
Email: Send Email
Country: United States
Website: https://trulyclear.com/

Celebrating a Remarkable Life: Katherine J. Batsis at the Festival of Books

Katherine J. Batsis will feature her memoir “Dr. Andrew Batsis, Husband! Dentist! Kiwanian! Santa Claus?” at the Los Angeles Times Festival of Books. The book celebrates her husband’s life, blending personal anecdotes with cultural insights, earning acclaim for its heartfelt narrative. This event marks a significant tribute to Dr. Batsis’s impactful legacy.

Katherine J. Batsis, an esteemed writer and teacher from Concord, Massachusetts, is set to talk about her first book, “Dr. Andrew Batsis, Husband! Dentist! Santa Claus?” at the Los Angeles Times Festival of Books from April 20th to 22nd. The event, which is renowned for celebrating literary culture, gives authors a chance to show off their work to an extensive audience of book lovers and industry professionals.

Katherine J. Batsis was born in Concord, Massachusetts, and went to Lesley College and Simmons College. She has worked as an educational media specialist in Toms River, New Jersey, for over 25 years. In addition to her work duties, she is known for being involved in school and library associations at the local, county, and statewide levels. She is also involved in music and part-time business ventures. She showcases her talents in square, round, and folk dancing and performs with the singing group Go for Baroque.

Katherine’s book, which was inspired by her husband’s life and work, gives a vivid picture of Dr. Andrew Batsis, a man who was a proud husband, a kind dentist, a busy Kiwanian, and a man who looked like Santa Claus. His story of kindness and service throughout his life is truly felt in the community and serves as an example for others to follow.

The memoir has been thoughtfully divided into three parts: The Memorial Tribute, Personal Reflections, and Kiwanis. Together, they give readers a full picture of Dr. Batsis’s life. The story beautifully combines Greek and American cultures through stories, recipes, and letters, showing a life full of traditions and service. At the end of the book, Key Club International awarded him the Key of Honor following his passing, demonstrating how significantly he impacted Kiwanis’ youth programs.

Critics and readers alike praise the memoir for its engaging narrative and heartfelt depiction of Dr. Batsis’s life. Comments from readers emphasize the book’s ability to connect them personally with Dr. Batsis, celebrating his life’s work and legacy. The memoir is praised for its thoughtful structure, blending elements of the memorial service with personal reflections and cultural insights while highlighting Dr. Batsis’s charismatic and impactful persona.

As Katherine prepares to present her work at the Los Angeles Times Festival of Books, the significance of this event extends beyond a simple promotion. This event is significant for more than just promoting Katherine’s work. This is a celebration of her husband’s life, sharing their combined experiences and recognizing Dr. Batsis’s huge impact on their community and beyond. She can honor her husband’s memory at this event, showing the depth and breadth of his life and his lasting impact on everyone who knew him.

Katherine J. Batsis’s participation in the Los Angeles Times Festival of Books is not just a literary milestone but a heartfelt tribute to her husband’s enduring legacy. Her memoir, “Dr. Andrew Batsis, Husband! Dentist! Kiwanian! Santa Claus?” is a testament to a well-lived life filled with love, service, and an enduring commitment to community values.

Media Contact
Company Name: Inks & Bindings
Contact Person: Alison Lee
Email: Send Email
Phone: 7142495529
Country: United States
Website: https://www.inksandbindings.com/

Founder Chris Gleason Leads His Company Into Texas Tax Loan Marketplace With Bold New Vision: Complete Transparency

Founder Chris Gleason Leads His Company Into Texas Tax Loan Marketplace With Bold New Vision: Complete Transparency
Simplicite Tax Loans (Pronounced “Simplicity”) sees consumer-education as the key to expanding the Texas property tax loan marketplace.

April 15, 2024 – Chris Gleason is the founder of Simplicite Tax Loans, an innovative property tax lender with offices in San Antonio, Texas. Besides the goal of “simplicity” being at the forefront of the consumer-experience, he also wants to educate consumers on the realities of property tax loans. The belief is that if property tax loans were better understood, and property owners were better equipped to make informed decisions around their property taxes, that more tax bills would wind up getting paid by a property tax lender.

As a national property tax group, Gleason and his team specialize in a number of different types of financing transactions that revolve around property taxes. In Texas in particular, they see property tax loans as a means of empowering Texas property owners to battle back against burdensome property tax rates – saving substantial sums of money in the process.

Simplicite will offer property owners something unique that has never been offered before: one-on-one strategy sessions with trained tax experts that are equipped to identify both the cheapest and most ideal solution for paying off past due property tax bills, even if the solution isn’t a loan from the company itself.

Some simple math clearly show that property owners who utilize tax loans stand to save 50% or more on interest and penalties that they would otherwise be charged by the tax collector. However, statistics also show that most property owners who take a tax loan don’t understand that their savings could be significantly greater. With even a rudimentary understanding of property tax loans, as well as just a few basic negotiating skills, property owners would be able to significantly reduce their property tax loan costs.

Gleason and his team expertly craft customized solutions for each of their clients that will highlight their expected savings but also consider strategies that the property owner should pursue to reduce future taxes. Simplicite clients not only get their property tax bill paid, they also walk away with clear gameplan to attack and reduce their future tax bills utilizing all of the tools that could possibly be at their disposal.

The company wants to be a stepping-stone on every property owner’s path to peace of mind, financial freedom, and their piece of the American Dream. More information can be found at https://www.simplicitetaxloans.com.

Media Contact
Company Name: Simplicite Tax Loans
Contact Person: Chris Gleason
Email: Send Email
Phone: +1-210-939-2002
Country: United States
Website: http://www.simplicitetaxloans.com/